News
Efanesoctocog alfa needs to be priced at less than 53 and 59% of current price for conventional and distributional cost-effectiveness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback